Suchergebnisse - "Perrone, Francesco"

PubPharm (44)

1

Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®)

enthalten in: Tumori | 2023

von Caminiti, C. | Bryce, J. | Riva, S. | +28

2

Effect of bevacizumab in advanced low grade serous ovarian cancer : Data from the MITO 22 trial

enthalten in: Gynecologic oncology | 2023

von Musacchio, L. | Turinetto, M. | Arenare, L. | +18

3

Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3) : a multicentre, open-label, randomised, controlled, phase 2 trial

enthalten in: The Lancet. Oncology | 2023

von Pignata, S. | Scambia, G. | Schettino, C. | +128

CommentIn: Lancet Oncol. 2023 Mar;24(3):201-203. - PMID 37052963

4

Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer : a multicenter, observational, retrospective analysis of MITO Group (MITO 22)

enthalten in: British journal of cancer | 2022

von Musacchio, L. | Califano, D. | Bartoletti, M. | +26

5

Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC : The BEVERLY Multicenter Randomized Phase 3 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Piccirillo, M. | Bonanno, L. | Garassino, M. | +30

6

Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer : phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2022

von Schettino, C. | Musacchio, L. | Bartoletti, M. | +14

7

Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients : the phase IV MITO-16A/MaNGO-OV2A study

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2021

von Daniele, G. | Raspagliesi, F. | Scambia, G. | +30

8

Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Cascinu, S. | Berardi, R. | Bianco, R. | +22

9

Multicenter Single-Arm, Two-Stage Phase 2 Study of Panitumumab in Patients With Cetuximab-Refractory Metastatic Colorectal Cancer : The PACER Trial

enthalten in: Clinical colorectal cancer | 2020

von Piccirillo, M. | Avallone, A. | Carlomagno, C. | +18

10

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

enthalten in: Journal of translational medicine | 2020

von Perrone, F. | Piccirillo, M. | Ascierto, P. | +134

ErratumIn: J Transl Med. 2021 Oct 21;19(1):442. - PMID 34674735

1
2
3
4
5
Nächster »
[5]